Leiomyosarcoma Clinical Trials in Boston, MA

Leiomyosarcoma Clinical Trials in Boston, MA

View the best 10 leiomyosarcoma medical studies in Boston, Massachusetts. Access promising new therapies by applying to a Boston-based Leiomyosarcoma clinical trial.

Trials in Boston, Massachusetts

Here are the top 5 medical studies for leiomyosarcoma in Boston, Massachusetts

Image of Sarcoma Oncology Center in Los Angeles, United States.

Doxorubicin +1 More

Anti-tumor antibiotic

Recruiting1 awardPhase 2 & 3
This trial will test if a combo of two chemo drugs can prolong progression-free survival in those with metastatic leiomyosarcoma.
Image of Dana-Farber - Harvard Cancer Center LAO in Boston, United States.

Pegylated Liposomal Doxorubicin Hydrochloride +1 More

Anti-tumor antibiotic

Recruiting1 awardPhase 1
This trial tests a new chemo combo to treat advanced sarcoma, aiming to shrink/stabilize the tumor cells.
Image of Children's Hospital of Orange County (Pediatrics [up to 25 years old]) in Orange, United States.

Tabelecleucel

Virus Therapy

Recruiting1 awardPhase 2
This trial tests tabelecleucel, a treatment using special immune cells, in patients with certain diseases related to the Epstein-Barr virus (EBV) who can't use or don't respond to standard treatments. It works by enhancing the immune system's ability to attack virus-infected cells. Tabelecleucel is being tested for recurring or hard-to-treat EBV-related diseases.
Image of Lifespan Cancer Institute at Rhode Island Hospital in Providence, United States.

NM32-2668

Cancer Vaccine

Recruiting1 awardPhase 1
This trial is testing a new drug called NM32-2668 in adult patients with advanced solid tumors. The main goals are to check the safety and effectiveness of the drug, find the highest safe dose
Image of Children's Hospital of Alabama in Birmingham, United States.

Ifosfamide +2 More

Alkylating agents

Recruiting1 awardPhase 2 & 3
This trial is testing whether a new drug called pazopanib, when combined with chemotherapy and radiation, works better for patients with a specific type of soft tissue cancer. Pazopanib helps stop cancer cells from growing, while chemotherapy and radiation kill the cells. The goal is to see if this combination can improve treatment outcomes.

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.